Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CHRO
Stock Latest News
The Fly
Zymeworks price target raised to $52 from $50 at Jefferies
16h ago
CHRO
ZYME
Premium
The Fly
Roche says Sefaxersen trial shows meaningful reduction in proteinuria
16h ago
CHRO
IONS
Premium
The Fly
Roche reports Sefaxersen achieved 43.1% reduction in proteinuria in trial
17h ago
CHRO
Premium
The Fly
Zymeworks signs collaboration and license agreement with Roche for ZW209
1d ago
CHRO
ZYME
Premium
The Fly
Roche upgraded to Buy from Hold at Deutsche Bank
1d ago
CHRO
Premium
The Fly
Roche reports 9M group sales CHF 46.5B vs. CHF 45.9B last year
2d ago
CHRO
Premium
The Fly
Roche confirms FY26 outlook
2d ago
CHRO
Premium
The Fly
Genentech announces new Phase III data for fenebrutinib
3d ago
CHRO
Premium
The Fly
Roche intends to make comeback with oncology pill treatment, Bloomberg says
3d ago
CHRO
Premium
The Fly
Roche upgraded to Outperform from Underperform at Oddo BHF
4d ago
CHRO
Premium
The Fly
Hansoh Pharmaceutical enters collaboration, license agreement with Roche
5d ago
CHRO
Premium
The Fly
Genentech announces FDA approval of Enspryng for the treatment of TED
8d ago
CHRO
Premium
The Fly
Roche’s Genentech announces new one-year data from Phase III Meerkat, Sandcat
13d ago
CHRO
Premium
The Fly
Genentech announces FDA approval of Tecentriq combination
15d ago
CHRO
Premium
The Fly
FDA approves Genentech’s atezolizumab combo for Stage III dMMR colon cancer
16d ago
CHRO
Premium
The Fly
Roche delivers laboratory equipment to support Ebola testing in DRC
17d ago
CHRO
Premium
The Fly
Alector price target raised to $3 from $2 at Morgan Stanley
18d ago
ALEC
CHRO
Premium
The Fly
Korsana Biosciences initiated with a Buy at Guggenheim on KRSA-028 potential
19d ago
CHRO
KRSA
Premium
The Fly
AFT, Natera announce launch of AFT-70 NAVIGATE
19d ago
CHRO
NTRA
Premium
The Fly
Alector enters exclusive AL050 global licensing agreement with Genentech
19d ago
ALEC
CHRO
Premium
The Fly
Genentech, Breastcancer.org launch ‘About Damn Time’ campaign
23d ago
CHRO
Premium
The Fly
Roche’s Genentech reports new data from Voyager study of Vabysmo
23d ago
CHRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
